All In Biotech

Free tool

FAERS Monitor: Kaletra

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021906 or its brand name (Kaletra, Lopinavir, Ritonavir). Reports on generic versions are filed under their own applications.

Reports

13,489

Serious

12,415

92% of reports

Hospitalization

5,010

Death reported

1,781

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug interaction1,338
  • depression1,141
  • nausea791
  • drug exposure during pregnancy778
  • diarrhoea774
  • foetal exposure during pregnancy757
  • anxiety712
  • vomiting712
  • off label use695
  • pain692
  • emotional distress578
  • renal failure540
  • pyrexia526
  • anhedonia510
  • anaemia452

Reports by year received

View as table
YearReports
2004761
2005608
2006677
2007725
2008999
20091,056
2010922
2011628
2012681
2013469
2014576
2015587
2016407
2017268
2018312
2019427
20201,446
2021862
2022473
2023217
2024137
2025177
202669

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,670 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug exposure during pregnancySignal77836.534.126,245
anhedoniaSignal51030.828.314,427
foetal exposure during pregnancySignal75714.613.79,560
drug interactionSignal1,33813.312.615,133
depressionSignal1,1417.97.46,857
emotional distressSignal5787.56.93,239
renal failureSignal5406.45.92,441
anxietySignal7123.93.61,555
anaemiaSignal4523.73.4895
pyrexiaSignal5262.42.2423
vomitingSignal7122.42.2571
diarrhoea7741.91.7322
pain6921.81.6232
nausea7911.61.5164
off label use6951.21.233

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.